Structure‐Guided Optimization and Biological Validation of 1,3,4‐Thiadiazole‐Based SIRT2 Inhibitors Reinforcing Channel Entrance Interactions
Authors:
- Ahmet Bugra AkselAAAhmet Bugra Aksel
- Fikriye OzgencilFOFikriye Ozgencil
- Filiz Bakar‐AtesFiliz Bakar‐Ates
- Habibe Beyza GunindiHGHabibe Beyza Gunindi
- Alberto MassarottiAMAlberto Massarotti
- Erva OzkanEOErva Ozkan
- Selen Gozde KayaSKSelen Gozde Kaya
- Mahmut GozelleMGMahmut Gozelle
- Yesim OzkanYOYesim Ozkan
- Gokcen ErenGEGokcen Eren
Open Access
- 10 March 2026
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 87 (2) , e70256
Abstract
SIRT2, the cytoplasmic member of the sirtuin family, is generally acknowledged to promote cancer and contribute to the progression of various pathologies, including neurodegeneration, inflammation, obesity, and bacterial infection through the deacetylation of target substrates. In our previous efforts we identified potent and highly selective SIRT2 inhibitors with IC 50 values in the micromolar range. To further optimize their activity, we performed molecular docking‐guided design and subsequent synthesis of a series of novel 1,3,4‐thiadiazole derivatives. SIRT inhibitory screening identified that ST131 and ST132 achieved moderate inhibitory effects against SIRT2 with IC 50 values of 8.95 and 6.62 µM, respectively. Moreover, cellular assays in MCF‐7 breast cancer cells revealed that ST132 has shown an antiproliferative effect, as well as increased acetylated α‐tubulin expression levels, which is typically consistent with SIRT2 inhibition. In addition, docking studies were performed to analyze and rationalize the structural differences responsible for SIRT2 activity, shedding light on the importance of the interactions occurring at the entrance of the binding site. Finally, molecular mechanics‐generalized born surface area (MM‐GBSA) and molecular dynamics (MD) simulation approaches were conducted to verify the stability of ST132 in the complex with SIRT2.Keywords
This publication has 51 references indexed in Scilit:
- Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situJournal of Clinical Pathology, 2012
- An unusual taxodione derivative from hairy roots of Salvia austriacaFitoterapia, 2012
- The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cellsHaematologica, 2011
- SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C ActivityCancer Cell, 2011
- SIRT2 regulates NF-κB-dependent gene expression through deacetylation of p65 Lys310Journal of Cell Science, 2010
- SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2Molecular Cancer Therapeutics, 2010
- The SIRT2 Deacetylase Regulates Autoacetylation of p300Molecular Cell, 2008
- SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restrictionAging Cell, 2007
- Structure of the histone deacetylase SIRT2Nature Structural & Molecular Biology, 2001
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983